S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › DRUG › Research report
← DRUG page
XStocksXray
Market X-Ray report · 19 October 2026

Bright Minds Biosciences Inc (DRUG)

Canadian Securities Exchange · Canada · prices in CAD · close of 19 Oct 2026

Key indicators

Last closeCAD 74.55
52-week range68.02 – 170.00
Return, 1 month / 3 months−12.8% / −30.9%
Return, 1 year / 3 years−22.7% / +3,400.0%
TrendBelow its 200-day average
RSI (14)43
Volatility (1 year)67.5%
Worst drawdown (1 year)-47.5%
Average daily value traded0.07M CAD
Dividend yield–

Market X-Ray price-based

64/ 100 · High confidence · ahead of 74% of stocks on this exchange
Trend54
Momentum38
Stability (higher is calmer)89
Liquidity85
Income–

Five-year price chart navy: price · brown: 200-day average

-6.5330.0366.591031402021-102023-012024-042025-072026-10

Summary

Bright Minds Biosciences Inc (DRUG) trades on the Canadian Securities Exchange in Canada. It last closed at CAD 74.55 on 19 October 2026.

Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 71 of 268 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 22.7% and over the last three months it fell 30.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Bright Minds Biosciences Inc (DRUG)

The five lenses in numbers each metric is ranked against the other stocks on Canadian Securities Exchange

Lens and metricValueScoreReading
Trend54 · FairMixed trend against its averages.
Above 200-day average-28.2%
From 52-week high-43.5%
Momentum38 · WeakLagging most stocks on this exchange.
3-month return-30.9%
6-month return-39.6%
12-month return, skipping the last month-11.4%
Stability (higher is calmer)89 · StrongCalmer than most: low volatility and shallow drawdowns.
Volatility, 1 year (lower is calmer)67.5%
Worst drawdown, 1 year (smaller is calmer)-47.5%
Liquidity85 · StrongTrades actively.
Average daily value traded0.07M CAD
Zero-volume days3.3%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
  • Liquidity: Trades actively.

Weak spots

  • Momentum: Lagging most stocks on this exchange.

Returns

1 week−3.3%
1 month−12.8%
3 months−30.9%
6 months−39.6%
1 year−22.7%
3 years+3,400.0%
5 years–

Signals

50-day / 200-day average90.27 / 103.87
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)3.34

Technical summary

DailyBearish3 bullish · 4 neutral · 9 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Canadian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026